Image

Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain

Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain

Recruiting
25-65 years
All
Phase N/A

Powered by AI

Overview

The purpose of this research study is to test whether Brief Behavioral Treatment for Insomnia (BBTI) delivered over the phone or Brief Mindfulness Training (BMT) delivered over the phone is better able to improve the symptoms of insomnia, reduce chronic pain, and slow the pace of biological aging in individuals with HIV and Chronic Pain.

Eligibility

Inclusion Criteria

Each subject must meet all of the following criteria and be confirmed with electronic medical records:

  1. Confirmed HIV diagnosis and currently a patient in the WashU Infectious Disease Clinic
  2. Age 25-65 years
  3. All people with HIV must be currently receiving stable antiretroviral therapy
  4. People with HIV with insomnia must report Insomnia Severity Index \>/= 15 at initial screening and meet DSM-5 diagnostic criteria for insomnia including sleep difficulty that occurs at least 3 times per week and has been a problem for at least 3 consecutive months
  5. People with HIV must also report the presence of chronic pain on the Brief Chronic Pain Screening Questionnaire and rate their chronic pain as \>/= 3 on a 0-10 scale of intensity.

Exclusion Criteria

Subjects will not be enrolled if any of the following criteria exist and confirmed with electronic medical records:

  1. History of stroke in past 12 months
  2. Active cancer with treatment
  3. Heart disease
  4. Uncontrolled hypertension
  5. Epilepsy
  6. Active pregnancy
  7. Reynaud's disease
  8. Traumatic injury or surgical procedure within the last 12 months
  9. Acute infection as suggested by thermometry temperature \>100.4
  10. Serious psychiatric disorder (bipolar disorder, psychotic disorder)
  11. Active suicidal ideation
  12. Evidence for severe obstructive sleep apnea (AHI \>30/hr) according to Home Sleep Monitoring or presence of another sleep disorder other than insomnia (i.e., not insomnia) as indicated by SCISD-R

Study details
    Chronic Pain
    Insomnia
    HIV

NCT07270406

Washington University School of Medicine

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.